Thirona is a high-tech company in Nijmegen focusing on development and marketing of automated analysis tools for medical images. Since its establishment in 2014, Thirona has developed three software products focusing on the analysis of thoracic CT scans (LungQ), chest X-rays (CAD4TB), and retinal images (RetCAD). Thirona is ISO 13485 compliant and all products have obtained CE certification and are actively used all over the world.
Our products use state-of-the-art image processing techniques such as deep learning. Thirona has developed a cloud solution as a service for its products based on AWS.
Our products use state-of-the-art image processing techniques such as deep learning. Thirona has developed a cloud solution as a service for its products based on AWS.
Location: Netherlands, Gelderland, Nijmegen
Employees: 11-50
Total raised: $8.06M
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | Heran Part... | heranpartn... |
| 21.11.2021 | Borski Fun... | borskifund... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.09.2023 | Grant | $8.06M | - |
Mentions in press and media 9
| Date | Title | Description |
| 20.08.2024 | Thirona's retina business unit acquired by Revenio Group | Nijmegen, the Netherlands By joining forces with iCare, a market leader in eye care solutions, Thirona Retina is poised to enhance patient outcomes and drive innovation in eye care. Leveraging iCare’s market presence and expertise, Thirona ... |
| 24.04.2024 | Voiant and Thirona announce commercial partnership for full scope services in imaging-based clinical trials for pulmonary diseases | Voiant & Thirona Announce Commercial Partnership Voiant (USA) and Thirona (The Netherlands) are pleased to announce they have entered a global commercial partnership, combining Voiant's expertise in supporting clinical trials in pulmona... |
| 23.01.2024 | AI Breakthrough for Lung Disease: Thirona’s LungQ Receives FDA Clearance | What You Should Know: – Thirona, a pioneer in AI-powered lung analysis, received a major boost for its cutting-edge technology LungQ™ with the U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest update, v3.0.0. – This FD... |
| 14.09.2023 | Thirona secures EUR 7,5m via investment round and EIC grant | Nijmegen, the Netherlands – Thirona, a global company specialized in advanced analysis of thoracic CT images with artificial intelligence, is thrilled to announce the successful completion of its new investment. The Company has secured EUR ... |
| 11.09.2023 | Dutch AI-powered medtech Thirona raises €7.5M to drive precision medicine innovations | Read this article in: Nijmegen-based Thirona, a company that specialises in advanced analysis of thoracic CT images with artificial intelligence (AI), announced on Monday that it has secured €7.5M in a fresh round of funding. This funding i... |
| 26.06.2023 | Dutch AI medical image analysis company Thirona secures grant from EIC to revolutionise lung treatment using AI | The Netherlands-based Thirona, a company that specialises in advanced CT image analysis with artificial intelligence, has been awarded funding by the European Innovation Council (EIC). The EIC grant will allow Thirona to accelerate progress... |
| 29.10.2021 | Thirona closes Financing Round with HERAN Partners and Borski Fund | Thirona, one of the leading companies specialised in artificial intelligence (AI) for medical image analysis, has closed its financing round with Belgian investment fund HERAN Partners and Borski Fund from the Netherlands. The proceeds of t... |
| 28.10.2021 | HERAN Partners invests in category leader for medical image analysis: Thirona | Thirona (Nijmegen, NL), one of the leading companies specialised in artificial intelligence (AI) for medical image analysis, has closed its financing round with Belgian investment fund HERAN Partners and Borski Fund from the Netherlands. Th... |
| 26.03.2020 | These Dutch startups join hands for ‘Radiology of the Future’ project, bag €1.5M funding from ERDF | Medical images can be analysed more accurately, more effectively, and easier using Artificial Intelligence. It takes time to develop an algorithm, which functions even better than an average physician. And, there are advantages such as redu... |